HDV Biotin - Diasome Pharmaceuticals

Drug Profile

HDV Biotin - Diasome Pharmaceuticals

Alternative Names: Oral HDV biotin

Latest Information Update: 11 Dec 2015

Price : $50

At a glance

  • Originator Diasome Pharmaceuticals
  • Class Coenzymes; Imidazoles; Small molecules; Vitamins
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Obesity

Most Recent Events

  • 11 Dec 2015 Phase-II clinical trials in Obesity in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top